FLAC

Frazier Lifesciences Acquisition Corp. currently has no substantial operational activities. Its primary objective is to execute a business combination, encompassing strategies like mergers, share exchanges, asset acquisitions, or reorganizations, with one or more companies within the biotechnology industry. This firm, established in 2020, is headquartered in Seattle, Washington.